EUVIMEDEUVIMED entdecken
Open Access

COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation

Lanting Yang, Shangbin Tang, Jingchuan Guo, Nico Gabriel, Walid F Gellad, Utibe R Essien, Jared W Magnani, Inmaculada Hernandez

American Journal of Cardiovascular Drugs · 2024

DOI: 10.1007/s40256-024-00671-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Cardiovascular Drugs, 2024. Verfasst von Lanting Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmacy, University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, 9500 Gilman Dr, Room 2244, …. Hauptthemen laut MEDLINE: COVID-19, Atrial Fibrillation, Anticoagulants, Stroke. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, Pharmaceutical Research and Manufacturers of America Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Atrial FibrillationAnticoagulantsStrokeHumansAgedFemaleMaleRetrospective StudiesAged, 80 and overAdministration, OralRisk FactorsProportional Hazards ModelsSARS-CoV-2

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Division of Clinical Pharmacy, University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, 9500 Gilman Dr, Room 2244, La Jolla, CA, 92093, USA.
  • Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, FL, USA.
  • Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.
  • Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Center for the Study of Healthcare Innovation, Implementation and Policy, Greater Los Angeles VA Healthcare System, Los Angeles, CA, USA.

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • Pharmaceutical Research and Manufacturers of America Foundation
  • National Heart, Lung, and Blood Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Yang, L., Tang, S., Guo, J., Gabriel, N., Gellad, W. F., Essien, U. R., Magnani, J. W., & Hernandez, I. (2024). COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation. American Journal of Cardiovascular Drugs. https://doi.org/10.1007/s40256-024-00671-3

Vancouver

Yang L, Tang S, Guo J, Gabriel N, Gellad WF, Essien UR, et al. COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation. American Journal of Cardiovascular Drugs. 2024. doi:10.1007/s40256-024-00671-3

BibTeX
@article{Yang2024,
  author = {Yang, Lanting and Tang, Shangbin and Guo, Jingchuan and Gabriel, Nico and Gellad, Walid F and Essien, Utibe R and Magnani, Jared W and Hernandez, Inmaculada},
  title = {COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation},
  journal = {American Journal of Cardiovascular Drugs},
  year = {2024},
  doi = {10.1007/s40256-024-00671-3}
}
Kostenlos starten →